Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...
As of Wednesday, February 04, Zenas BioPharma, Inc.’s ZBIO share price has surged by 10.09%, which has investors questioning ...
Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives.
Key market opportunities include advancing early melanoma detection through enhanced screening technologies and growing demand for novel immunotherapies and biologics. The high incidence of melanoma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results